Logo image of NWH-DB-I.CA

NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) Stock Price, Forecast & Analysis

Canada - Toronto Stock Exchange - TSX:NWH-DB-I - CA667495AK14

104.8 CAD
-0.95 (-0.9%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

3

Overall NWH-DB-I gets a fundamental rating of 3 out of 10. We evaluated NWH-DB-I against 37 industry peers in the Diversified REITs industry. While NWH-DB-I is still in line with the averages on profitability rating, there are concerns on its financial health. NWH-DB-I does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • NWH-DB-I had positive earnings in the past year.
  • In the past year NWH-DB-I had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NWH-DB-I reported negative net income in multiple years.
  • Each year in the past 5 years NWH-DB-I had a positive operating cash flow.
NWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • NWH-DB-I has a Return On Assets (0.82%) which is in line with its industry peers.
  • NWH-DB-I has a Return On Equity (3.06%) which is comparable to the rest of the industry.
  • NWH-DB-I has a worse Return On Invested Capital (3.41%) than 70.27% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NWH-DB-I is below the industry average of 5.57%.
  • The last Return On Invested Capital (3.41%) for NWH-DB-I is above the 3 year average (3.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROIC 3.41%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.4%
ROIC(5y)3.4%
NWH-DB-I.CA Yearly ROA, ROE, ROICNWH-DB-I.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • NWH-DB-I's Profit Margin of 11.90% is in line compared to the rest of the industry. NWH-DB-I outperforms 51.35% of its industry peers.
  • The Operating Margin of NWH-DB-I (61.05%) is better than 75.68% of its industry peers.
  • In the last couple of years the Operating Margin of NWH-DB-I has declined.
  • NWH-DB-I's Gross Margin of 74.32% is amongst the best of the industry. NWH-DB-I outperforms 81.08% of its industry peers.
  • In the last couple of years the Gross Margin of NWH-DB-I has remained more or less at the same level.
Industry RankSector Rank
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
OM growth 3Y-1.41%
OM growth 5Y-1.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
NWH-DB-I.CA Yearly Profit, Operating, Gross MarginsNWH-DB-I.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

2

2. Health

2.1 Basic Checks

  • NWH-DB-I has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NWH-DB-I has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NWH-DB-I has more shares outstanding
  • NWH-DB-I has a better debt/assets ratio than last year.
NWH-DB-I.CA Yearly Shares OutstandingNWH-DB-I.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NWH-DB-I.CA Yearly Total Debt VS Total AssetsNWH-DB-I.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 3.50 indicates that NWH-DB-I is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.50, NWH-DB-I belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
  • The Debt to FCF ratio of NWH-DB-I is 24.51, which is on the high side as it means it would take NWH-DB-I, 24.51 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 24.51, NWH-DB-I is doing worse than 70.27% of the companies in the same industry.
  • NWH-DB-I has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
  • NWH-DB-I's Debt to Equity ratio of 1.47 is on the low side compared to the rest of the industry. NWH-DB-I is outperformed by 70.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Altman-Z 3.5
ROIC/WACC0.46
WACC7.36%
NWH-DB-I.CA Yearly LT Debt VS Equity VS FCFNWH-DB-I.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • NWH-DB-I has a Current Ratio of 0.16. This is a bad value and indicates that NWH-DB-I is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NWH-DB-I has a worse Current ratio (0.16) than 64.86% of its industry peers.
  • A Quick Ratio of 0.16 indicates that NWH-DB-I may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.16, NWH-DB-I is doing worse than 64.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
NWH-DB-I.CA Yearly Current Assets VS Current LiabilitesNWH-DB-I.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

  • NWH-DB-I shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.98%, which is quite impressive.
  • Looking at the last year, NWH-DB-I shows a very negative growth in Revenue. The Revenue has decreased by -32.34% in the last year.
  • Measured over the past years, NWH-DB-I shows a small growth in Revenue. The Revenue has been growing by 4.78% on average per year.
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-I.CA Yearly Revenue VS EstimatesNWH-DB-I.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-I.CA Yearly EPS VS EstimatesNWH-DB-I.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

  • NWH-DB-I is valuated quite expensively with a Price/Earnings ratio of 524.00.
  • NWH-DB-I's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, NWH-DB-I is valued quite expensively.
Industry RankSector Rank
PE 524
Fwd PE N/A
NWH-DB-I.CA Price Earnings VS Forward Price EarningsNWH-DB-I.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • NWH-DB-I's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, NWH-DB-I is valued more expensive than 91.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 220.65
EV/EBITDA 112.9
NWH-DB-I.CA Per share dataNWH-DB-I.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 10.04%, NWH-DB-I is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.04, NWH-DB-I pays a better dividend. On top of this NWH-DB-I pays more dividend than 94.59% of the companies listed in the same industry.
  • NWH-DB-I's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

  • The dividend of NWH-DB-I decreases each year by -13.72%.
  • NWH-DB-I does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-13.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 154.63% of the earnings are spent on dividend by NWH-DB-I. This is not a sustainable payout ratio.
DP154.63%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-I.CA Yearly Income VS Free CF VS DividendNWH-DB-I.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
NWH-DB-I.CA Dividend Payout.NWH-DB-I.CA Dividend Payout, showing the Payout Ratio.NWH-DB-I.CA Dividend Payout.PayoutRetained Earnings

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-I (1/16/2026, 7:00:00 PM)

104.8

-0.95 (-0.9%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-11
Earnings (Next)03-09
Inst Owners10.73%
Inst Owner ChangeN/A
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap26.20B
Revenue(TTM)417.64M
Net Income(TTM)49.70M
Analysts70
Price Target113.91 (8.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.32
Dividend Growth(5Y)-13.72%
DP154.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.3%
PT rev (3m)-1.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 524
Fwd PE N/A
P/S 62.73
P/FCF 220.65
P/OCF 217.4
P/B 16.14
P/tB 17.03
EV/EBITDA 112.9
EPS(TTM)0.2
EY0.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.47
FCFY0.45%
OCF(TTM)0.48
OCFY0.46%
SpS1.67
BVpS6.49
TBVpS6.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.41
Profitability
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROCE 4.73%
ROIC 3.41%
ROICexc 3.46%
ROICexgc 3.52%
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
FCFM 28.43%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.4%
ROIC(5y)3.4%
ROICexc(3y)3.44%
ROICexc(5y)3.45%
ROICexgc(3y)3.5%
ROICexgc(5y)3.52%
ROCE(3y)4.73%
ROCE(5y)4.72%
ROICexgc growth 3Y6.32%
ROICexgc growth 5Y0.97%
ROICexc growth 3Y6.47%
ROICexc growth 5Y1.1%
OM growth 3Y-1.41%
OM growth 5Y-1.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Debt/EBITDA 9.29
Cap/Depr 80.78%
Cap/Sales 0.43%
Interest Coverage 1.76
Cash Conversion 46.86%
Profit Quality 238.9%
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.5
F-Score5
WACC7.36%
ROIC/WACC0.46
Cap/Depr(3y)24.87%
Cap/Depr(5y)24.57%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35%
EBIT growth 3Y5.76%
EBIT growth 5Y2.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.08%
FCF growth 3Y-11.68%
FCF growth 5Y-7.73%
OCF growth 1Y-11.91%
OCF growth 3Y-11.5%
OCF growth 5Y-7.59%

NORTHWEST HEALTHCARE PRO / NWH-DB-I.CA FAQ

Can you describe the business of NORTHWEST HEALTHCARE PRO?

Northwest Healthcare Properties Real Estate Investment Trust engages in the provision of access to a portfolio of international healthcare real estate infrastructure to investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2010-03-23. The company is a global investor and operator of healthcare infrastructure assets. The company provides investors with access to a portfolio of international healthcare real estate infrastructure of interest in a diversified portfolio of about 168 income-producing properties and 15.8 million square feet of gross leasable area located throughout major markets in North America, Australasia, Brazil, and Europe. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies. The company leverages its global workforce in eight countries to serve as a long-term real estate partner to healthcare operators. The company owns, manages, acquires, and develops healthcare assets in and around key healthcare locations and clusters of outpatient facilities in urban locations in major cities.


What is the stock price of NORTHWEST HEALTHCARE PRO today?

The current stock price of NWH-DB-I.CA is 104.8 CAD. The price decreased by -0.9% in the last trading session.


How is the ChartMill rating for NORTHWEST HEALTHCARE PRO?

NWH-DB-I.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.